Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
December 2012 Volume 4 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December 2012 Volume 4 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude mice

  • Authors:
    • Cheng-Hua Zhou
    • Ya-Ya Wan
    • Xiang-Hua Chu
    • Zheng Song
    • Shu-Hua Xing
    • Yu-Qing Wu
    • Xiao-Xing Yin
  • View Affiliations / Copyright

    Affiliations: School of Pharmacy, Xuzhou Medical College, Xuzhou, Jiangsu 221004, P.R. China, Pharmacy Department, Affiliated Hospital of Qingdao University Medical College, Huangdao branch, Qingdao, Shandong 266500, P.R. China, Department of Anesthetic Pharmacology, Xuzhou Medical College, Xuzhou, Jiangsu 221004, P.R. China
  • Pages: 1259-1263
    |
    Published online on: September 21, 2012
       https://doi.org/10.3892/ol.2012.932
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Urotensin II (UII), a somatostatin-like cyclic peptide, was originally isolated from the fish urophysis. Our previous study showed that UII stimulates the proliferation of A549 lung adenocarcinoma cells and promotes tumor growth in a nude mouse xenograft model, suggesting that UII may contribute to the pathogenesis of lung adenocarcinoma. In this study, the underlying mechanism for UII to promote lung adenocarcinoma growth was explored by observing the effect of UII on the tumor inflammatory microenvironment in tumor-bearing nude mice. Immunohistochemical analysis showed that UII promoted the infiltration of CD68+ tumor-associated macrophages (TAMs) in the tumor microenvironment. Enzyme-linked immunosorbent assay (ELISA) demonstrated that UII promoted the release of interleukin‑6 (IL‑6), tumor necrosis factor-α (TNF‑α) and matrix metalloproteinase‑9 (MMP‑9). Western blot analysis showed that UII promoted the activation of nuclear factor‑κB (NF‑κB). These findings suggest that the enhanced levels of IL‑6, TNF‑α and MMP‑9 in the tumor microenvironment, which likely resulted from increased activation of NF‑κB induced by UII, may be one of the important mechanisms by which UII promotes lung adenocarcinoma growth. These findings imply that antagonists of UII or urotensin II-receptor (UT‑R) have potential for the prevention and treatment of lung adenocarcinoma.
View Figures

Figure 1

Figure 2

Figure 3

View References

1. 

F BalkwillA MantovaniInflammation and cancer: back to Virchow?Lancet357539545200110.1016/S0140-6736(00)04046-011229684

2. 

TA GondaS TuTC WangChronic inflammation, the tumor microenvironment and carcinogenesisCell Cycle820052013200910.4161/cc.8.13.898519550141

3. 

J MarxCancer research. Inflammation and cancer: the link grows strongerScience306966968200410.1126/science.306.5698.96615528423

4. 

LM CoussensZ WerbInflammation and cancerNature420860867200210.1038/nature0132212490959

5. 

JC KangJS ChenCH LeeJJ ChangYS ShiehIntratumoral macrophage counts correlate with tumor progression in colorectal cancerJ Surg Oncol102242248201010.1002/jso.2161720740582

6. 

JY LinXY LiN TadashiP DongClinical significance of tumor-associated macrophage infiltration in supraglottic laryngeal carcinomaChin J Cancer30280286201110.5732/cjc.010.1033621439250

7. 

T FujiwaraJ FukushiS YamamotoMacrophage infiltration predicts a poor prognosis for human ewing sarcomaAm J Pathol17911571170201110.1016/j.ajpath.2011.05.03421771572

8. 

H LuW OuyangC HuangInflammation, a key event in cancer developmentMol Cancer Res4221233200610.1158/1541-7786.MCR-05-026116603636

9. 

WC ChoCK KwanS YauPP SoPC PoonJS AuThe role of inflammation in the pathogenesis of lung cancerExpert Opin Ther Targets1511271137201110.1517/14728222.2011.59980121751938

10. 

DS O’CallaghanD O’DonnellF O’ConnellKJ O’ByrneThe role of inflammation in the pathogenesis of non-small cell lung cancerJ Thorac Oncol520242036201021155185

11. 

G LeeTC WalserSM DubinettChronic inflammation, chronic obstructive pulmonary disease, and lung cancerCurr Opin Pulm Med15303307200910.1097/MCP.0b013e32832c975a19417670

12. 

T WalserX CuiJ YanagawaSmoking and lung cancer: the role of inflammationProc Am Thorac Soc5811815200810.1513/pats.200809-100TH19017734

13. 

H TakahashiH OgataR NishigakiDH BroideM KarinTobacco smoke promotes lung tumorigenesis by triggering IKKbetaand JNK1-dependent inflammationCancer Cell178997201010.1016/j.ccr.2009.12.00820129250

14. 

CG SlatoreDH AuAJ LittmanJA SatiaE WhiteAssociation of nonsteroidal anti-inflammatory drugs with lung cancer: results from a large cohort studyCancer Epidemiol Biomarkers Prev1812031207200910.1158/1055-9965.EPI-08-111019293309

15. 

A AkhmedkhanovP TonioloA Zeleniuch-JacquotteKL KoenigRE ShoreAspirin and lung cancer in womenBr J Cancer874953200210.1038/sj.bjc.660037012085255

16. 

D PearsonJE ShivelyBR ClarkUrotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishesProc Natl Acad Sci USA7750215024198010.1073/pnas.77.8.50216107911

17. 

Y CoulouarnI LihrmannS JegouCloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cordProc Natl Acad Sci USA951580315808199810.1073/pnas.95.26.158039861051

18. 

NA ElshourbagySA DouglasU ShabonMolecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkeyBr J Pharmacol136922200210.1038/sj.bjp.0704671

19. 

Y CoulouarnS JégouH TostivintH VaudryI LihrmannCloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursorsFEBS Lett4572832199910486557

20. 

RS AmesHM SarauJK ChambersHuman urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14Nature401282286199910.1038/4580910499587

21. 

AP DavenportJJ MaguireUrotensin II: fish neuropeptide catches orphan receptorTrends Pharmacol Sci218082200010.1016/S0165-6147(00)01449-810689357

22. 

DG JohnsZ AoD NaselskyUrotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediatorsNaunyn Schmiedebergs Arch Pharmacol370238250200410.1007/s00210-004-0980-z15549273

23. 

JP SegainM Rolli-DerkinderenN GervoisD Raingeard de la BlétièreG LoirandP PacaudUrotensin II is a new chemotactic factor for UT receptor-expressing monocytesJ Immunol179901909200710.4049/jimmunol.179.2.90117617581

24. 

P CirilloS De RosaM PacileoHuman urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial cells: an emerging role for urotensin II in cardiovascular diseaseJ Thromb Haemost6726736200810.1111/j.1538-7836.2008.02923.x

25. 

N BousetteL PatelSA DouglasEH OhlsteinA GiaidIncreased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aortaAtherosclerosis176117123200410.1016/j.atherosclerosis.2004.03.02315306183

26. 

M Birker-RobaczewskaC BoukhadraR StuderC MuellerC BinkertO NaylerThe expression of urotensin II receptor (U2R) is up-regulated by interferon-gammaJ Recept Signal Transduct Res23289305200310.1081/RRS-12002697214753294

27. 

YQ WuZ SongCH ZhouSH XingDS PeiJN ZhengExpression of urotensin II and its receptor in human lung adenocarcinoma A549 cells and the effect of urotensin II on lung adenocarcinoma growth in vitro and in vivoOncol Rep2411791184201020878108

28. 

J ShiD ZhengY LiuMH ShamP TamF FarzanehR XuOverexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude miceCancer Res6516871692200510.1158/0008-5472.CAN-04-274915753363

29. 

A KawaharaS HattoriJ AkibaInfiltration of thymidine phosphorylase-positive macrophages is closely associated with tumor angiogenesis and survival in intestinal type gastric cancerOncol Rep24405415201010.3892/or_0000087320596627

30. 

H KuraharaH ShinchiY MatakiSignificance of M2-polarized tumor-associated macrophage in pancreatic cancerJ Surg Res167e211219200910.1016/j.jss.2009.05.02619765725

31. 

CH LeeI EspinosaS VrijaldenhovenPrognostic significance of macrophage infiltration in leiomyosarcomasClin Cancer Res1414231430200810.1158/1078-0432.CCR-07-171218316565

32. 

M RyderRA GhosseinJC Ricarte-FilhoJA KnaufJA FaginIncreased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancerEndocr Relat Cancer1510691074200810.1677/ERC-08-003618719091

33. 

A SicaRole of tumour-associated macrophages in cancer-related inflammationExp Oncol32153158201021403610

34. 

BB AggarwalS ShishodiaSK SandurMK PandeyG SethiInflammation and cancer: how hot is the link?Biochem Pharmacol7216051621200610.1016/j.bcp.2006.06.02916889756

35. 

J SunRD RamnathL ZhiR TamizhselviM BhatiaSubstance P enhances NF-kappaB transactivation and chemokine response in murine macrophages via ERK1/2 and p38 MAPK signaling pathwaysAm J Physiol Cell Physiol294C15861596200810.1152/ajpcell.00129.200818434625

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhou C, Wan Y, Chu X, Song Z, Xing S, Wu Y and Yin X: Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude mice. Oncol Lett 4: 1259-1263, 2012.
APA
Zhou, C., Wan, Y., Chu, X., Song, Z., Xing, S., Wu, Y., & Yin, X. (2012). Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude mice. Oncology Letters, 4, 1259-1263. https://doi.org/10.3892/ol.2012.932
MLA
Zhou, C., Wan, Y., Chu, X., Song, Z., Xing, S., Wu, Y., Yin, X."Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude mice". Oncology Letters 4.6 (2012): 1259-1263.
Chicago
Zhou, C., Wan, Y., Chu, X., Song, Z., Xing, S., Wu, Y., Yin, X."Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude mice". Oncology Letters 4, no. 6 (2012): 1259-1263. https://doi.org/10.3892/ol.2012.932
Copy and paste a formatted citation
x
Spandidos Publications style
Zhou C, Wan Y, Chu X, Song Z, Xing S, Wu Y and Yin X: Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude mice. Oncol Lett 4: 1259-1263, 2012.
APA
Zhou, C., Wan, Y., Chu, X., Song, Z., Xing, S., Wu, Y., & Yin, X. (2012). Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude mice. Oncology Letters, 4, 1259-1263. https://doi.org/10.3892/ol.2012.932
MLA
Zhou, C., Wan, Y., Chu, X., Song, Z., Xing, S., Wu, Y., Yin, X."Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude mice". Oncology Letters 4.6 (2012): 1259-1263.
Chicago
Zhou, C., Wan, Y., Chu, X., Song, Z., Xing, S., Wu, Y., Yin, X."Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude mice". Oncology Letters 4, no. 6 (2012): 1259-1263. https://doi.org/10.3892/ol.2012.932
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team